Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing Type
4
Filing Date
4/17/2024
Updated
4/18/24, 4:06 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership